Tonix Pharmaceuticals (NASDAQ:TNXP) stock is falling hard on Monday after the company’s shares underwent a reverse stock split this morning. That reverse stock split saw Tonix Pharmaceuticals consolidate 32 shares of TNXP stock into a single share. The company continues to trade shares under the same ticker but now uses 890260847 as its new CUSIP number. Traders don’t often react well to reverse stock splits and that appears to be the case today. The stock is dropping with more than 427,000 shares traded as ...